{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:29:20Z","timestamp":1761611360460},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11596-014-1364-3","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T09:52:36Z","timestamp":1418032356000},"page":"856-860","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics and tissue distribution of clevidipine and its metabolite in dogs and rats"],"prefix":"10.1007","volume":"34","author":[{"given":"Ying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-meng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu-qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,6]]},"reference":[{"issue":"3","key":"1364_CR1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/TCRM.S5312","volume":"5","author":"WF Peacock","year":"2009","unstructured":"Peacock WF, Angeles JE, Soto KM, et al. Parenteral clevidipine for the acute control of blood pressure in the critically ill patient: a review. Ther Clin Risk Manag, 2009, 5(3):627\u2013634","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"1364_CR2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00000542-200004000-00016","volume":"92","author":"H Ericsson","year":"2000","unstructured":"Ericsson H, Bredberg U, Eriksson U, et al. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers. Anesthesiology, 2000, 92(4):993\u20131001","journal-title":"Anesthesiology"},{"issue":"2","key":"1364_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.pap.0000249908.55361.de","volume":"14","author":"C Feldstein","year":"2007","unstructured":"Feldstein C. Management of hypertensive crises. Am J Ther, 2007, 14(2), 135\u2013139","journal-title":"Am J Ther"},{"issue":"5","key":"1364_CR4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/cc2351","volume":"7","author":"J Varon","year":"2003","unstructured":"Varon, J, Marik, PE. Clinical review: the management of hypertensive crises. Crit Care, 2003, 7(5):374\u2013384","journal-title":"Crit Care"},{"issue":"99","key":"1364_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-6576.1993.tb03819.x","volume":"37","author":"JH Levy","year":"1993","unstructured":"Levy JH. The ideal agent for perioperative hypertension and potential cytoprotective effects. Acta Anaesthesiol Scand Suppl, 1993, 37(99):20\u201325","journal-title":"Acta Anaesthesiol Scand Suppl"},{"issue":"24","key":"1364_CR6","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2146\/ajhp070105","volume":"64","author":"TW Brooks","year":"2007","unstructured":"Brooks TW, Finch CK, Lobo BL, et al. Blood pressure management in acute hypertensive emergency. Am J Health Syst Pharm, 2007, 64(24):2579\u20132582","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1364_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1540-8191.2006.00214.x","volume":"21","author":"AT Cheung","year":"2006","unstructured":"Cheung AT. Exploring an optimum intra\/postoperative management strategy for acute hypertension in the cardiac surgery patient. J Card Surg, 2006, 21(1):8\u201314","journal-title":"J Card Surg"},{"issue":"10","key":"1364_CR8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00228-012-1260-3","volume":"68","author":"WB Smith","year":"2012","unstructured":"Smith WB, Marbury TC, Komjathy SF, et al. Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension. Eur J Clin Pharmacol, 2012, 68(10):1385\u20131394","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"1364_CR9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1213\/01.ane.0000281443.13712.b9","volume":"5","author":"JH Levy","year":"2007","unstructured":"Levy JH, Mancao MY, Gitter R, et al. Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. Anaesth Analg, 2007, 5(4):918\u2013925","journal-title":"Anaesth Analg"},{"issue":"1","key":"1364_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1213\/ane.0b013e3181732e53","volume":"107","author":"N Singla","year":"2008","unstructured":"Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, doubleblind, placebo-controlled trial. Anesth Analg, 2008, 107(1):59\u201367","journal-title":"Anesth Analg"},{"issue":"3","key":"1364_CR11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1527-3466.2004.tb00143.x","volume":"22","author":"M Nordlander","year":"2004","unstructured":"Nordlander M, Sjoquist PO, Ericsson H, et al. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultra short-acting calcium antagonist for rapid blood pressure control. Cardiovasc Drug Rev, 2004, 22(3):227\u2013250","journal-title":"Cardiovasc Drug Rev"},{"issue":"1","key":"1364_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-0987(98)00058-X","volume":"8","author":"H Ericsson","year":"1999","unstructured":"Ericsson H, Tholander B, Regirdh CG. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashortacting calcium antagonist metabolised by esterases, in different animal species and man. Eur J Pharm Sci, 1999, 8(1):29\u201337","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1364_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002280050594","volume":"55","author":"H Ericsson","year":"1991","unstructured":"Ericsson H, Fakt C, Hoglund L, et al. Pharmacokinetics and pharmacodynamics of clevidipine in healthy volunteers after intravenous infusion. Eur J Clin Pharmacol, 1991, 55(1): 61\u201367","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"1364_CR14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/dmd.105.006569","volume":"34","author":"JG Zhang","year":"2006","unstructured":"Zhang JG, Dehal SS, Ho T, et al. Human cytochrome P450 induction and inhibition potential of clevidipine and its primary metabolite H152\/81. Drug Metab Dispos, 2006, 34(5): 734\u2013737","journal-title":"Drug Metab Dispos"},{"key":"1364_CR15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jpba.2014.08.018","volume":"100","author":"Y Zhou","year":"2014","unstructured":"Zhou Y, Li HQ, He XM, et al. Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study. J Pharm Biomed Anal, 2014, 100:294\u2013299","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"1364_CR16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/00000542-200205000-00010","volume":"96","author":"JM Bailey","year":"2002","unstructured":"Bailey JM, Lu W, Levy JH, et al. Clevidipine in adult cardiac surgical patients: a dose-finding study. Anesthesiology, 2002, 96(5):1086\u20131094","journal-title":"Anesthesiology"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-014-1364-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1364-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:11:05Z","timestamp":1559394665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-014-1364-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1007\/s11596-014-1364-3","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}